Product Information
ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1077 per EA under NDC 57237011490. Its NADAC has been published 597 times since Mar 18, 2015.
FDA first approved this application on Aug 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237011490
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALFUZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079060FDA Approved
8/30/2012
TE Code
AB
On Market Since
8/30/2012
Pharmacological Classes
Price Statistics
The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 597 times since Mar 18, 2015, and over the history we have for it it has declined 57.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1077 per EA |
|---|---|
| All-time high | $0.2625 (May 13, 2015) |
| All-time low | $0.1034 (Jan 22, 2025) |
| 52-week high | $0.1121 |
| 52-week low | $0.1052 |
| Median price | $0.1351 |
| Average price | $0.1447 |
| Largest weekly change | +32.0% (Nov 22, 2023) |
| Weeks tracked | 597 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1077 per EA (NDC 57237011490), effective Aug 19, 2026.
How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 57.9%. It has been tracked across 597 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?
Since Mar 18, 2015, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1034 (Jan 22, 2025) to a high of $0.2625 (May 13, 2015), with a median of $0.1351 per EA.
Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALFUZOSIN HCL ER 10 MG TABLET, is $0.1074 per EA — about 0% below ALFUZOSIN HCL ER 10 MG TABLET.
Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?
ALFUZOSIN HCL ER 10 MG TABLET (NDC 57237011490) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.